Genetic Variants in GCKR and Circulating FGF21 as Indicators of Metabolic Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease - Top-Institutions - MDSpire

Genetic Variants in GCKR and Circulating FGF21 as Indicators of Metabolic Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease

  • By

  • Asmaa Mohamed Fteah

  • Doaa Mamdouh Aly

  • Mohamed A. Elrefaiy

  • Ali Abdel Rahim

  • April 13, 2026

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hepatology
    • Genetics
    • Metabolic Diseases

  • #2

    University of California, San Diego (UCSD) School of Medicine
    University of California, San Diego (UCSD) School of Medicine

    San Diego, CA

    Key Differentiators

    • Hepatology
    • Endocrinology
    • Genomic Medicine

  • #3

    Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount Sinai

    New York, NY

    Key Differentiators

    • Hepatology
    • Genetics
    • Metabolic Research

  • #4

    University of Michigan Medical School
    University of Michigan Medical School

    Ann Arbor, MI

    Key Differentiators

    • Hepatology
    • Molecular Genetics
    • Metabolic Disorders

  • #5

    Stanford University School of Medicine
    Stanford University School of Medicine

    Stanford, CA

    Key Differentiators

    • Hepatology
    • Genomics
    • Endocrinology

Original Source(s)

Genetic Variants in GCKR and Circulating FGF21 as Indicators of Metabolic Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease

  • by Asmaa Mohamed Fteah, Doaa Mamdouh Aly, Mohamed A. Elrefaiy, Ali Abdel Rahim

  • April 13, 2026

Related Content

The Role of Total Small Bowel Length and its Measurement in Metabolic Bariatric Surgery. A Systematic Review

Hematological abnormalities in clinically diagnosed non-alcoholic steatohepatitis: prevalence, clinical correlates, and fibrosis risk in a case–control study from Qatar

Publisher Correction: Machine Learning Models for Predicting Significant Liver Fibrosis in Patients with Severe Obesity and Nonalcoholic Fatty Liver Disease